Table 3.
Pearson’s correlation between Ca, tP, and aP, daily Ca:tP ratio and daily Ca:aP ratio, and serum phosphorus, serum calcium, serum calcium to phosphorus ratio, FGF23, VitD, ALP, and OCN in gilts and barrows
| Gilts | Barrows | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Item | Weeka | tP intake, g/d | aP intake, g/d | Ca intake, g/d | Daily Ca:tP ratio | Daily Ca:aP ratio | tP intake, g/d | aP intake, g/d | Ca intake, g/d | Daily Ca:tP ratio | Daily Ca:aP ratio |
| Serum P, mmol/L | 1 | 0.24 | 0.58* | 0.27 | 0.76* | −0.76* | 0.16 | 0.55* | 0.21 | 0.61* | −0.61* |
| 4 | 0.12 | 0.32 | 0.15 | 0.33 | −0.33 | 0.31 | 0.42* | 0.33 | 0.22 | −0.22 | |
| 8 | 0.41* | 0.2 | 0.39* | −0.25 | 0.25 | 0.39* | 0.33 | 0.39* | −0.23 | 0.23 | |
| Serum Ca, mmol/L | 1 | 0.09 | −0.22 | 0.06 | −0.58* | 0.58* | 0.31 | −0.19 | 0.27 | −0.61* | 0.61* |
| 4 | 0.06 | −0.09 | 0.05 | −0.17 | 0.17 | 0.27 | 0.28 | 0.28 | 0.06 | −0.06 | |
| 8 | 0.57* | 0.50* | 0.58* | 0.01 | −0.01 | 0.46* | 0.33 | 0.45* | −0.26 | 0.26 | |
| Serum Ca:P ratio | 1 | −0.17 | −0.57* | −0.21 | −0.86* | 0.86* | −0.01 | −0.52* | −0.06 | −0.74* | 0.74* |
| 4 | −0.12 | −0.41* | −0.16 | −0.46* | 0.46* | −0.19 | −0.35 | −0.21 | −0.27 | 0.27 | |
| 8 | −0.05 | 0.1 | −0.04 | 0.25 | −0.25 | −0.23 | −0.21 | −0.23 | 0.14 | −0.14 | |
| Serum FGF23, pg/mL | 1 | 0.11 | −0.03 | 0.1 | −0.22 | 0.22 | −0.27 | −0.2 | −0.28 | 0.04 | −0.04 |
| 4 | −0.23 | −0.13 | −0.22 | 0.02 | −0.02 | 0.13 | 0.19 | 0.14 | 0.1 | −0.1 | |
| 8 | −0.14 | 0.01 | −0.13 | 0.2 | −0.2 | −0.07 | −0.07 | −0.07 | 0.05 | −0.05 | |
| Serum VitD, ng/mL | 1 | −0.12 | −0.08 | −0.12 | 0.07 | −0.07 | 0.12 | 0.38* | 0.15 | 0.33 | −0.33 |
| 4 | 0.12 | 0.05 | 0.12 | −0.04 | 0.04 | 0.14 | 0.07 | 0.14 | −0.06 | 0.06 | |
| 8 | −0.48* | −0.50* | −0.49* | −0.11 | 0.11 | −0.51* | −0.60* | −0.52* | −0.1 | 0.1 | |
| Serum ALP, U/L | 1 | −0.47* | −0.47* | −0.47* | −0.16 | 0.16 | −0.12 | −0.14 | −0.12 | −0.1 | 0.1 |
| 4 | −0.06 | 0.06 | −0.05 | 0.16 | −0.16 | −0.02 | 0.15 | −0.01 | 0.24 | −0.24 | |
| 8 | 0.32 | 0.44* | 0.34 | 0.21 | −0.21 | 0.32 | 0.31 | 0.32 | 0 | 0 | |
| Serum OCN, ng/mL |
1 | 0.60* | 0.45* | 0.59* | −0.11 | 0.11 | 0.50* | 0.29 | 0.50* | −0.19 | 0.19 |
| 4 | 0.11 | 0.25 | 0.13 | 0.24 | −0.24 | 0.04 | 0.12 | 0.05 | 0.11 | −0.11 | |
| 8 | 0.15 | 0.2 | 0.15 | 0.18 | −0.18 | 0.15 | 0.27 | 0.16 | 0.2 | −0.2 |
a Week 1: correlation between Ca, tP, and aP intake from days 1 to 7 and serum parameters from days 2 + 3 (in week 1); week 4: correlation between Ca, tP, and aP intake from days 22 to 28 and serum parameters 23 + 24 (in week 4); week 8: correlation between Ca, tP, and aP intake from days 50 to 56 and serum parameters days 52 + 53 (in week 8).
*|r| > 0.35 and P < 0.05.